Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”
Joint Authors
Zhang, Qing
Zhang, Haixu
Ding, Jiage
Liu, Hongyan
Li, Huizhong
Li, Hailong
Lu, Mengmeng
Miao, Yangna
Li, Liantao
Zheng, Junnian
Source
Journal of Immunology Research
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-03-27
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
In the article titled “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models” [1], there was a typographical error in Figure 4(b) where the label of the statistical difference symbol should be corrected as follows:
American Psychological Association (APA)
Zhang, Qing& Zhang, Haixu& Ding, Jiage& Liu, Hongyan& Li, Huizhong& Li, Hailong…[et al.]. 2019. Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”. Journal of Immunology Research،Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1175776
Modern Language Association (MLA)
Zhang, Qing…[et al.]. Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”. Journal of Immunology Research No. 2019 (2019), pp.1-2.
https://search.emarefa.net/detail/BIM-1175776
American Medical Association (AMA)
Zhang, Qing& Zhang, Haixu& Ding, Jiage& Liu, Hongyan& Li, Huizhong& Li, Hailong…[et al.]. Corrigendum to “Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models”. Journal of Immunology Research. 2019. Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1175776
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1175776
